John Martin, Ph.D.
Since 1996, Dr. Martin has been chairman and CEO of Gilead (www.gilead.com). The company’s portfolio of therapeutics aimed at infectious diseases includes eight marketed products: Truvada, Viread, Emtriva, AmBisome, Hepsera, Tamiflu, Vistide, and Macugen.
Dr. Martin, according to colleagues, is about winningon the basketball court, as well as in business and science. In both, this plain-spoken man quickly shares credit with the team. Dr. Martin places value on time, frequently flying with carry-on rather than checked luggage to avoid waiting at baggage claim. Dawn often finds him already at his desk, honing his reputation for handling both the science and the management aspects of his job exceptionally well.
Words of Wisdom: The first question that each of us should ask ourselves when we arrive at work in the morning is what can I do today to make a difference?